<DOC>
	<DOC>NCT02475616</DOC>
	<brief_summary>This is a single-center, placebo-controlled, randomized, double-blind, dose-escalation study to evaluate safety, tolerability, and PK of a single oral (PO) administration of PCO371 in healthy adult males. Caucasian and Japanese subjects will be randomized to receive either PCO371 or placebo.</brief_summary>
	<brief_title>A Single Ascending Dose Study of PCO371 in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male volunteers aged 18 to 45 years. Caucasian(BMI 1830 mg/kg2) or first generation japanese(BMI 1825kg/m2) Able and willing to abide by the protocol Evidence of any medical condition that could affect renal, hepatic, or cardiopulmonary functions.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>